Publications & Posters

Optimization And Qualification Of The Single Molecule Array Digital Immunoassay For Il-12p70 In Plasma Of Cancer Patients

BIOANAYLSIS

Gupta V, Kalia N, Yadav M, Noyes A, Good J, Hendricks R and Xu W

Bioanalysis. 2018;10:1413-1425

DOI: https://doi.org/10.4155/bio-2018-0083

Abstract

Aim:

Cytokine/chemokine levels can reflect the pharmacodynamics of checkpoint inhibitors. The single molecule array (Simoa) HD-1 is a sensitive next-generation immunoassay platform for quantification of low abundance proteins, with potential for cancer immunotherapy mechanism of action studies.

Results:

The Simoa IL-12p70 reagents, standard curve and test conditions were optimized for improved precision and linearity of dilution in plasma of cancer patients. The assay achieved a lower limit of quantification of 0.08 pg/ml, with 27/29 samples recording above lower limit of quantification, precision ≤20% CV and accuracy within 80-120%.

Conclusion:

Simoa enabled quantification of IL-12p70 at sub-pg/ml levels in cancer patients and was superior to Simple Plex™ and Aushon® in overall performance. This study qualifies the user-modified IL-12p70 immunoassay to measure pharmacodynamic changes in plasma during cancer immunotherapy.